Vedel @vedel_j · Apr 27, Apr 27, 2026, 8:55 AM Great overview of INHBE landscape! $ARWR $WVE $ALNY $LLY $AMGN $REGN baSeq @baSeqbio · Apr 27 The INHBE obesity landscape, 36 molecules in the Atlas database.9 in Phase 1, 9 preclinical, 18 at patent stage. siRNA dominates. China leads on filings, US leads on clinical.$ARWR $WVE $ALNY $LLY $AMGN $REGN View quoted post on X
Vedel @vedel_j · Apr 21, Apr 21, 2026, 8:22 PM $RVMD $ERAS $ANL. Credit: linkedin.com/posts/lasse-ve…
Vedel @vedel_j · Oct 29, 2025, Oct 29, 2025, 9:20 PM What is next for $BBIO in terms of early stage development? Seems like they passed on a lot of exciting programs to Gondola and BBOT, but only owns 29% and 17% of these. So what comes after current late stage successes?
Vedel @vedel_j · Sep 3, 2025, Sep 3, 2025, 7:45 PM $ARWR anyone who knows what happened to their lung directed programs - total silence about ARO-RAGE and ARO-MMP7 (also from Sarepta).
Vedel @vedel_j · Jul 17, 2025, Jul 17, 2025, 6:23 AM $ARWR $SRPT MMP7 IPF program not mentioned anywhere in yesterdays slides from Sarepta. Is the program dead?
